Онкопедиатрия. 2019; 6: 78-86
Подходы к лечению детей с эстезионейробластомой: обзор литературы
Горбунова Т. В., Родина А. Д., Шишков Р. В., Иванова Н. В., Глеков И. В., Малахова А. А., Поляков В. Г.
https://doi.org/10.15690/onco.v6i2.2019Аннотация
Список литературы
1. Benoit MM, Bhattacharyya N, Faquin W, Cunningham M. Cancer of the nasal cavity in the pediatric population. Pediatrics. 2008;121(1):е141–146. doi: 10.1542/peds.2007-1319.
2. Soler ZM, Smith TL. Endoscopic versus open craniofacial resection of esthesioneuroblastoma: what is the evidence? Laryngoscope. 2012;122(2):244– 245. doi: 10.1002/lary.22450.
3. Venkatramani R, Pan H, Furman WL, et al. Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer. 2016;63(3):465– 470. doi: 10.1002/pbc.25817.
4. Кручинина И.Л., Поляков В.Г. Эстезионейробластома в детском возрасте // Журнал ушных, носовых и горловых болезней. — 1979. — №39. — С. 31–33.
5. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014;18(Suppl 2):S149–156. doi: 10.1055/s-0034-1390014.
6. Capper D, Engel NW, Stichel D, et al. DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018;136(2):255–271. doi: 10.1007/s00401-018-1854-7.
7. Koch M, Constantinidis J, Dimmler A, et al. [Langzeiterfahrungen in der therapie des ästhesioneuroblastoms. (Article in German).]. Laryngorhinootologie. 2006;85(10):723–730.
8. Kumar S, Perlman E, Pack S, et al. Absence of EWS/ FL11 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing’s sarcoma family. Hum Pathol. 1999;30(11):1356–1360. doi: 10.1016/s0046-8177(99)90068-0.
9. Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget. 2016;7(32):52584–52596. doi: 10.18632/oncotarget.9683.
10. Van Gompel J, Gianinni C, Olsen K, et al. Longterm outcome of esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surg B Skull Base. 2012;73(5):331–336. doi: 10.1055/s-0032-1321512.
11. Malouf GG, Casiraghi O, Deutsch E, et al. Low and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 2013;49(6):1324–1334. doi: 10.1016/j.ejca.2012.12.008.
12. Меркулов О.А., Горбунова Т.В., Поляков В.Г. Метод трансназального эндоскопического удаления опухоли в комплексном лечении детей с эстезионейробластомой // Онкопедиатрия. — 2017. — Т.4. — №1. — С. 31–42. doi: 10.15690/onco.v4i1.1682.
13. Таболиновская Т.Д., Мудунов А.М., Алиева С.Б., и др. Эстезионейробластома (клиническое течение, отдаленные результаты) // Опухоли головы и шеи. — 2016. — Т.6. — №1 — С. 13–27. doi: 10.17650/2222-1468-2016-6-1-13-27.
14. Elkhatib AH, Soldatova L, Carrau RL, et al. Role of 18F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. Laryngoscope. 2017;127(2):321–324. doi: 10.1002/lary.26194.
15. Broski SM, Hunt CH, Johnson GB, et al. The added value of F-18-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med. 2012;53(8):1200–1206. doi: 10.2967/jnumed.112.102897.
16. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683–690. doi: 10.1016/S1470-2045(01)00558-7.
17. Patel SG, Singh B, Stambuk HE, et al. Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base. 2012;73(3):208–220. doi: 10.1055/s-0032-1311754.
18. Herr MW, Sethi RK, Meier JC, et al. Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base. 2014;75(1):58–64. doi: 10.1055/s-0033-1356493.
19. Hirose T, Scheithauer BW, Lopes MB, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995;76(1):4–19. doi: 10.1002/1097-0142(19950701)76:13.0.co;2-e.
20. Kumar R. Esthesioneuroblastoma: multimodal management and review of literature. World J Clin Cases. 2015;3(9):774–778. doi: 10.12998/wjcc.v3.i9.774.
21. Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1):51–59. doi: 10.1007/s12105-014-0547-3.
22. Дурнов Л.А., Голдобенко Г.В., Курмашов В.И. Детская онкология. — Курск, 1997. — 381 с.
23. Bisogno G, Soloni P, Conte M, et al. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12:117. doi: 10.1186/1471-2407-12-117.
24. Diaz EM, Johnigan RH, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005;27(2):138– 149. doi: 10.1002/hed.20127.
25. Gallia GL, Reh DD, Lane AP, et al. Endoscopic resection of esthesioneuroblastoma. J Clin Neurosci. 2012;19(11):1478–1482. doi: 10.1016/j.jocn.2012.03.011.
26. Harvey RJ, Nalavenkata S, Sacks R, et al. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma. Head Neck. 2017;39(12):2425–2432. doi: 10.1002/ hed.24912.
27. Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr. Opin. Otolaryngol. Curr Opin Otolaryngol Head Neck Surg. 2016;24(1):63–69. doi: 10.1097/MOO.0000000000000220.
28. Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol Ital. 2008;28(6):292– 297.
29. Unger F, Haselsberger K, Walch C, et al. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien). 2005;147(6):595– 601; discussion 601–602.
30. Lucas JT Jr, Ladra MM, MacDonald SM, et al. Proton radiotherapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015;62(9):1523–1528. doi: 10.1002/pbc.25494.
31. Zanation AM, Ferlito A, Rinaldo A, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol. 2010;267(11):1667–1671. doi: 10.1007/s00405-010-1360-6.
32. Monroe AT, Hinerman RW, Amdur RJ, et al. Radiation therapy for estesioneuroblastoma: rationale for elective neck irradiation. Head Neck. 2003;25(7):529– 534. doi: 10.1002/hed.10247.
33. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma. Continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg. 2006;132(2):134–138. doi: 10.1001/archotol.132.2.134.
34. Porter AB, Bernold DM, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008;90(2):201–204. doi: 10.1007/s11060-008-9645-y.
35. Kim D-W, Jo Y-H, Kim JH, et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer. 2004;101(10):2257–2260. doi: 10.1002/cncr.20648.
36. Kiyota N, Tahara M, Fujii S, et al. Nonplatinumbased chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma. A retrospective analysis of 12 cases. Cancer. 2008;112(4):885–891. doi: 10.1002/cncr.23246.
37. El Kababri M, Habrand JL, Valteau-Couanet D, et al. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review. J Pediatr Hematol Oncol. 2014;36(2):91–95. doi: 10.1097/MPH.0000000000000095.
Oncopediatrics. 2019; 6: 78-86
Approaches to the Treatment of Children with Esthesioneuroblastoma: Literature Review
Gorbunova Tatiana V., Rodina Anastasia D., Shishkov Ruslan V., Ivanova Natalia V., Glekov Igor V., Malachova Alina A., Polyakov Vladimir G.
https://doi.org/10.15690/onco.v6i2.2019Abstract
References
1. Benoit MM, Bhattacharyya N, Faquin W, Cunningham M. Cancer of the nasal cavity in the pediatric population. Pediatrics. 2008;121(1):e141–146. doi: 10.1542/peds.2007-1319.
2. Soler ZM, Smith TL. Endoscopic versus open craniofacial resection of esthesioneuroblastoma: what is the evidence? Laryngoscope. 2012;122(2):244– 245. doi: 10.1002/lary.22450.
3. Venkatramani R, Pan H, Furman WL, et al. Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer. 2016;63(3):465– 470. doi: 10.1002/pbc.25817.
4. Kruchinina I.L., Polyakov V.G. Estezioneiroblastoma v detskom vozraste // Zhurnal ushnykh, nosovykh i gorlovykh boleznei. — 1979. — №39. — S. 31–33.
5. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014;18(Suppl 2):S149–156. doi: 10.1055/s-0034-1390014.
6. Capper D, Engel NW, Stichel D, et al. DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018;136(2):255–271. doi: 10.1007/s00401-018-1854-7.
7. Koch M, Constantinidis J, Dimmler A, et al. [Langzeiterfahrungen in der therapie des ästhesioneuroblastoms. (Article in German).]. Laryngorhinootologie. 2006;85(10):723–730.
8. Kumar S, Perlman E, Pack S, et al. Absence of EWS/ FL11 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing’s sarcoma family. Hum Pathol. 1999;30(11):1356–1360. doi: 10.1016/s0046-8177(99)90068-0.
9. Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget. 2016;7(32):52584–52596. doi: 10.18632/oncotarget.9683.
10. Van Gompel J, Gianinni C, Olsen K, et al. Longterm outcome of esthesioneuroblastoma: Hyams grade predicts patient survival. J Neurol Surg B Skull Base. 2012;73(5):331–336. doi: 10.1055/s-0032-1321512.
11. Malouf GG, Casiraghi O, Deutsch E, et al. Low and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 2013;49(6):1324–1334. doi: 10.1016/j.ejca.2012.12.008.
12. Merkulov O.A., Gorbunova T.V., Polyakov V.G. Metod transnazal'nogo endoskopicheskogo udaleniya opukholi v kompleksnom lechenii detei s estezioneiroblastomoi // Onkopediatriya. — 2017. — T.4. — №1. — S. 31–42. doi: 10.15690/onco.v4i1.1682.
13. Tabolinovskaya T.D., Mudunov A.M., Alieva S.B., i dr. Estezioneiroblastoma (klinicheskoe techenie, otdalennye rezul'taty) // Opukholi golovy i shei. — 2016. — T.6. — №1 — S. 13–27. doi: 10.17650/2222-1468-2016-6-1-13-27.
14. Elkhatib AH, Soldatova L, Carrau RL, et al. Role of 18F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma. Laryngoscope. 2017;127(2):321–324. doi: 10.1002/lary.26194.
15. Broski SM, Hunt CH, Johnson GB, et al. The added value of F-18-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med. 2012;53(8):1200–1206. doi: 10.2967/jnumed.112.102897.
16. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683–690. doi: 10.1016/S1470-2045(01)00558-7.
17. Patel SG, Singh B, Stambuk HE, et al. Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base. 2012;73(3):208–220. doi: 10.1055/s-0032-1311754.
18. Herr MW, Sethi RK, Meier JC, et al. Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base. 2014;75(1):58–64. doi: 10.1055/s-0033-1356493.
19. Hirose T, Scheithauer BW, Lopes MB, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995;76(1):4–19. doi: 10.1002/1097-0142(19950701)76:13.0.co;2-e.
20. Kumar R. Esthesioneuroblastoma: multimodal management and review of literature. World J Clin Cases. 2015;3(9):774–778. doi: 10.12998/wjcc.v3.i9.774.
21. Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1):51–59. doi: 10.1007/s12105-014-0547-3.
22. Durnov L.A., Goldobenko G.V., Kurmashov V.I. Detskaya onkologiya. — Kursk, 1997. — 381 s.
23. Bisogno G, Soloni P, Conte M, et al. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12:117. doi: 10.1186/1471-2407-12-117.
24. Diaz EM, Johnigan RH, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005;27(2):138– 149. doi: 10.1002/hed.20127.
25. Gallia GL, Reh DD, Lane AP, et al. Endoscopic resection of esthesioneuroblastoma. J Clin Neurosci. 2012;19(11):1478–1482. doi: 10.1016/j.jocn.2012.03.011.
26. Harvey RJ, Nalavenkata S, Sacks R, et al. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma. Head Neck. 2017;39(12):2425–2432. doi: 10.1002/ hed.24912.
27. Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr. Opin. Otolaryngol. Curr Opin Otolaryngol Head Neck Surg. 2016;24(1):63–69. doi: 10.1097/MOO.0000000000000220.
28. Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol Ital. 2008;28(6):292– 297.
29. Unger F, Haselsberger K, Walch C, et al. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien). 2005;147(6):595– 601; discussion 601–602.
30. Lucas JT Jr, Ladra MM, MacDonald SM, et al. Proton radiotherapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015;62(9):1523–1528. doi: 10.1002/pbc.25494.
31. Zanation AM, Ferlito A, Rinaldo A, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol. 2010;267(11):1667–1671. doi: 10.1007/s00405-010-1360-6.
32. Monroe AT, Hinerman RW, Amdur RJ, et al. Radiation therapy for estesioneuroblastoma: rationale for elective neck irradiation. Head Neck. 2003;25(7):529– 534. doi: 10.1002/hed.10247.
33. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma. Continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg. 2006;132(2):134–138. doi: 10.1001/archotol.132.2.134.
34. Porter AB, Bernold DM, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008;90(2):201–204. doi: 10.1007/s11060-008-9645-y.
35. Kim D-W, Jo Y-H, Kim JH, et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer. 2004;101(10):2257–2260. doi: 10.1002/cncr.20648.
36. Kiyota N, Tahara M, Fujii S, et al. Nonplatinumbased chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma. A retrospective analysis of 12 cases. Cancer. 2008;112(4):885–891. doi: 10.1002/cncr.23246.
37. El Kababri M, Habrand JL, Valteau-Couanet D, et al. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review. J Pediatr Hematol Oncol. 2014;36(2):91–95. doi: 10.1097/MPH.0000000000000095.
События
-
К платформе Elpub присоединился журнал «The BRICS Health Journal» >>>
10 июн 2025 | 12:52 -
Журнал «Неотложная кардиология и кардиоваскулярные риски» присоединился к Elpub >>>
6 июн 2025 | 09:45 -
К платформе Elpub присоединился «Медицинский журнал» >>>
5 июн 2025 | 09:41 -
НЭИКОН принял участие в конференции НИИ Организации здравоохранения и медицинского менеджмента >>>
30 мая 2025 | 10:32 -
Журнал «Творчество и современность» присоединился к Elpub! >>>
27 мая 2025 | 12:38